img

Global NUP50 Antibody Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global NUP50 Antibody Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

NUP50 Antibody report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global NUP50 Antibody market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Demand from Immunochemistry (IHC) and Immunofluorescence (IF) are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for NUP50 Antibody industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, NUP50 Antibody key companies include Thermo Fisher Scientific, Aviva Systems Biology, LifeSpan BioSciences, Leading Biology, RayBiotech, OriGene Technologies, Novus Biologicals, Abcam and Bethyl Laboratories, etc. Thermo Fisher Scientific, Aviva Systems Biology, LifeSpan BioSciences are top 3 players and held % share in total in 2022.
NUP50 Antibody can be divided into Monoclonal and Polyclonal, etc. Monoclonal is the mainstream product in the market, accounting for % share globally in 2022.
NUP50 Antibody is widely used in various fields, such as Immunochemistry (IHC), Immunofluorescence (IF), Immunoprecipitation (IP) and Western Blot (WB), etc. Immunochemistry (IHC) provides greatest supports to the NUP50 Antibody industry development. In 2022, global % share of NUP50 Antibody went into Immunochemistry (IHC) filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global NUP50 Antibody market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Thermo Fisher Scientific
Aviva Systems Biology
LifeSpan BioSciences
Leading Biology
RayBiotech
OriGene Technologies
Novus Biologicals
Abcam
Bethyl Laboratories
ProSci
Abnova Corporation
Bioss
GeneTex
ABclonal Technology
Proteintech Group
Sino Biological
United States Biological
CUSABIO Technology
St John's Laboratory
Biobyt
Jingjie PTM BioLab
Wuhan Fine
Segment by Type
Monoclonal
Polyclonal

Segment by Application


Immunochemistry (IHC)
Immunofluorescence (IF)
Immunoprecipitation (IP)
Western Blot (WB)
ELISA
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the NUP50 Antibody market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, NUP50 Antibody introduction, etc. NUP50 Antibody Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of NUP50 Antibody market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.

Table of Content

1 Market Overview of NUP50 Antibody
1.1 NUP50 Antibody Market Overview
1.1.1 NUP50 Antibody Product Scope
1.1.2 NUP50 Antibody Market Status and Outlook
1.2 Global NUP50 Antibody Market Size Overview by Region 2018 VS 2022 VS 2033
1.3 Global NUP50 Antibody Market Size by Region (2018-2033)
1.4 Global NUP50 Antibody Historic Market Size by Region (2018-2023)
1.5 Global NUP50 Antibody Market Size Forecast by Region (2024-2033)
1.6 Key Regions, NUP50 Antibody Market Size (2018-2033)
1.6.1 North America NUP50 Antibody Market Size (2018-2033)
1.6.2 Europe NUP50 Antibody Market Size (2018-2033)
1.6.3 Asia-Pacific NUP50 Antibody Market Size (2018-2033)
1.6.4 Latin America NUP50 Antibody Market Size (2018-2033)
1.6.5 Middle East & Africa NUP50 Antibody Market Size (2018-2033)
2 NUP50 Antibody Market by Type
2.1 Introduction
2.1.1 Monoclonal
2.1.2 Polyclonal
2.2 Global NUP50 Antibody Market Size by Type: 2018 VS 2022 VS 2033
2.2.1 Global NUP50 Antibody Historic Market Size by Type (2018-2023)
2.2.2 Global NUP50 Antibody Forecasted Market Size by Type (2024-2033)
2.3 Key Regions Market Size by Type
2.3.1 North America NUP50 Antibody Revenue Breakdown by Type (2018-2033)
2.3.2 Europe NUP50 Antibody Revenue Breakdown by Type (2018-2033)
2.3.3 Asia-Pacific NUP50 Antibody Revenue Breakdown by Type (2018-2033)
2.3.4 Latin America NUP50 Antibody Revenue Breakdown by Type (2018-2033)
2.3.5 Middle East and Africa NUP50 Antibody Revenue Breakdown by Type (2018-2033)
3 NUP50 Antibody Market Overview by Application
3.1 Introduction
3.1.1 Immunochemistry (IHC)
3.1.2 Immunofluorescence (IF)
3.1.3 Immunoprecipitation (IP)
3.1.4 Western Blot (WB)
3.1.5 ELISA
3.1.6 Others
3.2 Global NUP50 Antibody Market Size by Application: 2018 VS 2022 VS 2033
3.2.1 Global NUP50 Antibody Historic Market Size by Application (2018-2023)
3.2.2 Global NUP50 Antibody Forecasted Market Size by Application (2024-2033)
3.3 Key Regions Market Size by Application
3.3.1 North America NUP50 Antibody Revenue Breakdown by Application (2018-2033)
3.3.2 Europe NUP50 Antibody Revenue Breakdown by Application (2018-2033)
3.3.3 Asia-Pacific NUP50 Antibody Revenue Breakdown by Application (2018-2033)
3.3.4 Latin America NUP50 Antibody Revenue Breakdown by Application (2018-2033)
3.3.5 Middle East and Africa NUP50 Antibody Revenue Breakdown by Application (2018-2033)
4 NUP50 Antibody Competition Analysis by Players
4.1 Global NUP50 Antibody Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in NUP50 Antibody as of 2022)
4.3 Date of Key Players Enter into NUP50 Antibody Market
4.4 Global Top Players NUP50 Antibody Headquarters and Area Served
4.5 Key Players NUP50 Antibody Product Solution and Service
4.6 Competitive Status
4.6.1 NUP50 Antibody Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Thermo Fisher Scientific
5.1.1 Thermo Fisher Scientific Profile
5.1.2 Thermo Fisher Scientific Main Business
5.1.3 Thermo Fisher Scientific NUP50 Antibody Products, Services and Solutions
5.1.4 Thermo Fisher Scientific NUP50 Antibody Revenue (US$ Million) & (2018-2023)
5.1.5 Thermo Fisher Scientific Recent Developments
5.2 Aviva Systems Biology
5.2.1 Aviva Systems Biology Profile
5.2.2 Aviva Systems Biology Main Business
5.2.3 Aviva Systems Biology NUP50 Antibody Products, Services and Solutions
5.2.4 Aviva Systems Biology NUP50 Antibody Revenue (US$ Million) & (2018-2023)
5.2.5 Aviva Systems Biology Recent Developments
5.3 LifeSpan BioSciences
5.3.1 LifeSpan BioSciences Profile
5.3.2 LifeSpan BioSciences Main Business
5.3.3 LifeSpan BioSciences NUP50 Antibody Products, Services and Solutions
5.3.4 LifeSpan BioSciences NUP50 Antibody Revenue (US$ Million) & (2018-2023)
5.3.5 Leading Biology Recent Developments
5.4 Leading Biology
5.4.1 Leading Biology Profile
5.4.2 Leading Biology Main Business
5.4.3 Leading Biology NUP50 Antibody Products, Services and Solutions
5.4.4 Leading Biology NUP50 Antibody Revenue (US$ Million) & (2018-2023)
5.4.5 Leading Biology Recent Developments
5.5 RayBiotech
5.5.1 RayBiotech Profile
5.5.2 RayBiotech Main Business
5.5.3 RayBiotech NUP50 Antibody Products, Services and Solutions
5.5.4 RayBiotech NUP50 Antibody Revenue (US$ Million) & (2018-2023)
5.5.5 RayBiotech Recent Developments
5.6 OriGene Technologies
5.6.1 OriGene Technologies Profile
5.6.2 OriGene Technologies Main Business
5.6.3 OriGene Technologies NUP50 Antibody Products, Services and Solutions
5.6.4 OriGene Technologies NUP50 Antibody Revenue (US$ Million) & (2018-2023)
5.6.5 OriGene Technologies Recent Developments
5.7 Novus Biologicals
5.7.1 Novus Biologicals Profile
5.7.2 Novus Biologicals Main Business
5.7.3 Novus Biologicals NUP50 Antibody Products, Services and Solutions
5.7.4 Novus Biologicals NUP50 Antibody Revenue (US$ Million) & (2018-2023)
5.7.5 Novus Biologicals Recent Developments
5.8 Abcam
5.8.1 Abcam Profile
5.8.2 Abcam Main Business
5.8.3 Abcam NUP50 Antibody Products, Services and Solutions
5.8.4 Abcam NUP50 Antibody Revenue (US$ Million) & (2018-2023)
5.8.5 Abcam Recent Developments
5.9 Bethyl Laboratories
5.9.1 Bethyl Laboratories Profile
5.9.2 Bethyl Laboratories Main Business
5.9.3 Bethyl Laboratories NUP50 Antibody Products, Services and Solutions
5.9.4 Bethyl Laboratories NUP50 Antibody Revenue (US$ Million) & (2018-2023)
5.9.5 Bethyl Laboratories Recent Developments
5.10 ProSci
5.10.1 ProSci Profile
5.10.2 ProSci Main Business
5.10.3 ProSci NUP50 Antibody Products, Services and Solutions
5.10.4 ProSci NUP50 Antibody Revenue (US$ Million) & (2018-2023)
5.10.5 ProSci Recent Developments
5.11 Abnova Corporation
5.11.1 Abnova Corporation Profile
5.11.2 Abnova Corporation Main Business
5.11.3 Abnova Corporation NUP50 Antibody Products, Services and Solutions
5.11.4 Abnova Corporation NUP50 Antibody Revenue (US$ Million) & (2018-2023)
5.11.5 Abnova Corporation Recent Developments
5.12 Bioss
5.12.1 Bioss Profile
5.12.2 Bioss Main Business
5.12.3 Bioss NUP50 Antibody Products, Services and Solutions
5.12.4 Bioss NUP50 Antibody Revenue (US$ Million) & (2018-2023)
5.12.5 Bioss Recent Developments
5.13 GeneTex
5.13.1 GeneTex Profile
5.13.2 GeneTex Main Business
5.13.3 GeneTex NUP50 Antibody Products, Services and Solutions
5.13.4 GeneTex NUP50 Antibody Revenue (US$ Million) & (2018-2023)
5.13.5 GeneTex Recent Developments
5.14 ABclonal Technology
5.14.1 ABclonal Technology Profile
5.14.2 ABclonal Technology Main Business
5.14.3 ABclonal Technology NUP50 Antibody Products, Services and Solutions
5.14.4 ABclonal Technology NUP50 Antibody Revenue (US$ Million) & (2018-2023)
5.14.5 ABclonal Technology Recent Developments
5.15 Proteintech Group
5.15.1 Proteintech Group Profile
5.15.2 Proteintech Group Main Business
5.15.3 Proteintech Group NUP50 Antibody Products, Services and Solutions
5.15.4 Proteintech Group NUP50 Antibody Revenue (US$ Million) & (2018-2023)
5.15.5 Proteintech Group Recent Developments
5.16 Sino Biological
5.16.1 Sino Biological Profile
5.16.2 Sino Biological Main Business
5.16.3 Sino Biological NUP50 Antibody Products, Services and Solutions
5.16.4 Sino Biological NUP50 Antibody Revenue (US$ Million) & (2018-2023)
5.16.5 Sino Biological Recent Developments
5.17 United States Biological
5.17.1 United States Biological Profile
5.17.2 United States Biological Main Business
5.17.3 United States Biological NUP50 Antibody Products, Services and Solutions
5.17.4 United States Biological NUP50 Antibody Revenue (US$ Million) & (2018-2023)
5.17.5 United States Biological Recent Developments
5.18 CUSABIO Technology
5.18.1 CUSABIO Technology Profile
5.18.2 CUSABIO Technology Main Business
5.18.3 CUSABIO Technology NUP50 Antibody Products, Services and Solutions
5.18.4 CUSABIO Technology NUP50 Antibody Revenue (US$ Million) & (2018-2023)
5.18.5 CUSABIO Technology Recent Developments
5.19 St John's Laboratory
5.19.1 St John's Laboratory Profile
5.19.2 St John's Laboratory Main Business
5.19.3 St John's Laboratory NUP50 Antibody Products, Services and Solutions
5.19.4 St John's Laboratory NUP50 Antibody Revenue (US$ Million) & (2018-2023)
5.19.5 St John's Laboratory Recent Developments
5.20 Biobyt
5.20.1 Biobyt Profile
5.20.2 Biobyt Main Business
5.20.3 Biobyt NUP50 Antibody Products, Services and Solutions
5.20.4 Biobyt NUP50 Antibody Revenue (US$ Million) & (2018-2023)
5.20.5 Biobyt Recent Developments
5.21 Jingjie PTM BioLab
5.21.1 Jingjie PTM BioLab Profile
5.21.2 Jingjie PTM BioLab Main Business
5.21.3 Jingjie PTM BioLab NUP50 Antibody Products, Services and Solutions
5.21.4 Jingjie PTM BioLab NUP50 Antibody Revenue (US$ Million) & (2018-2023)
5.21.5 Jingjie PTM BioLab Recent Developments
5.22 Wuhan Fine
5.22.1 Wuhan Fine Profile
5.22.2 Wuhan Fine Main Business
5.22.3 Wuhan Fine NUP50 Antibody Products, Services and Solutions
5.22.4 Wuhan Fine NUP50 Antibody Revenue (US$ Million) & (2018-2023)
5.22.5 Wuhan Fine Recent Developments
6 North America
6.1 North America NUP50 Antibody Market Size by Country (2018-2033)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe NUP50 Antibody Market Size by Country (2018-2033)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific NUP50 Antibody Market Size by Region (2018-2033)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America NUP50 Antibody Market Size by Country (2018-2033)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa NUP50 Antibody Market Size by Country (2018-2033)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 NUP50 Antibody Market Dynamics
11.1 NUP50 Antibody Industry Trends
11.2 NUP50 Antibody Market Drivers
11.3 NUP50 Antibody Market Challenges
11.4 NUP50 Antibody Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market NUP50 Antibody Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2033
Table 2. Global NUP50 Antibody Market Size by Region (2018-2023) & (US$ Million)
Table 3. Global NUP50 Antibody Market Size Share by Region (2018-2023)
Table 4. Global NUP50 Antibody Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 5. Global NUP50 Antibody Forecasted Market Size Share by Region (2024-2033)
Table 6. Global NUP50 Antibody Market Size (US$ Million) by Type: 2018 VS 2022 VS 2033
Table 7. Global NUP50 Antibody Market Size by Type (2018-2023) & (US$ Million)
Table 8. Global NUP50 Antibody Revenue Market Share by Type (2018-2023)
Table 9. Global NUP50 Antibody Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 10. Global NUP50 Antibody Revenue Market Share by Type (2024-2033)
Table 11. North America NUP50 Antibody Revenue by Type (2018-2023) & (US$ Million)
Table 12. North America NUP50 Antibody Revenue by Type (2024-2033) & (US$ Million)
Table 13. Europe NUP50 Antibody Revenue by Type (2018-2023) & (US$ Million)
Table 14. Europe NUP50 Antibody Revenue by Type (2024-2033) & (US$ Million)
Table 15. Asia-Pacific NUP50 Antibody Revenue by Type (2018-2023) & (US$ Million)
Table 16. Asia-Pacific NUP50 Antibody Revenue by Type (2024-2033) & (US$ Million)
Table 17. Latin America NUP50 Antibody Revenue by Type (2018-2023) & (US$ Million)
Table 18. Latin America NUP50 Antibody Revenue by Type (2024-2033) & (US$ Million)
Table 19. Middle East and Africa NUP50 Antibody Revenue by Type (2018-2023) & (US$ Million)
Table 20. Middle East and Africa NUP50 Antibody Revenue by Type (2024-2033) & (US$ Million)
Table 21. Global NUP50 Antibody Market Size (US$ Million) by Application: 2018 VS 2022 VS 2033
Table 22. Global NUP50 Antibody Market Size by Application (2018-2023) & (US$ Million)
Table 23. Global NUP50 Antibody Revenue Market Share by Application (2018-2023)
Table 24. Global NUP50 Antibody Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 25. Global NUP50 Antibody Revenue Market Share by Application (2024-2033)
Table 26. North America NUP50 Antibody Revenue by Application (2018-2023) & (US$ Million)
Table 27. North America NUP50 Antibody Revenue by Application (2024-2033) & (US$ Million)
Table 28. Europe NUP50 Antibody Revenue by Application (2018-2023) & (US$ Million)
Table 29. Europe NUP50 Antibody Revenue by Application (2024-2033) & (US$ Million)
Table 30. Asia-Pacific NUP50 Antibody Revenue by Application (2018-2023) & (US$ Million)
Table 31. Asia-Pacific NUP50 Antibody Revenue by Application (2024-2033) & (US$ Million)
Table 32. Latin America NUP50 Antibody Revenue by Application (2018-2023) & (US$ Million)
Table 33. Latin America NUP50 Antibody Revenue by Application (2024-2033) & (US$ Million)
Table 34. Middle East and Africa NUP50 Antibody Revenue by Application (2018-2023) & (US$ Million)
Table 35. Middle East and Africa NUP50 Antibody Revenue by Application (2024-2033) & (US$ Million)
Table 36. Global NUP50 Antibody Revenue (US$ Million) by Players (2018-2023)
Table 37. Global NUP50 Antibody Revenue Market Share by Players (2018-2023)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in NUP50 Antibody as of 2022)
Table 39. Date of Key Players Enter into NUP50 Antibody Market
Table 40. Global NUP50 Antibody Key Players Headquarters and Area Served
Table 41. NUP50 Antibody Product Solution and Service
Table 42. Global NUP50 Antibody Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Thermo Fisher Scientific Basic Information List
Table 45. Thermo Fisher Scientific Description and Business Overview
Table 46. Thermo Fisher Scientific NUP50 Antibody Products, Services and Solutions
Table 47. Revenue (US$ Million) in NUP50 Antibody Business of Thermo Fisher Scientific (2018-2023)
Table 48. Thermo Fisher Scientific Recent Developments
Table 49. Aviva Systems Biology Basic Information List
Table 50. Aviva Systems Biology Description and Business Overview
Table 51. Aviva Systems Biology NUP50 Antibody Products, Services and Solutions
Table 52. Revenue (US$ Million) in NUP50 Antibody Business of Aviva Systems Biology (2018-2023)
Table 53. Aviva Systems Biology Recent Developments
Table 54. LifeSpan BioSciences Basic Information List
Table 55. LifeSpan BioSciences Description and Business Overview
Table 56. LifeSpan BioSciences NUP50 Antibody Products, Services and Solutions
Table 57. Revenue (US$ Million) in NUP50 Antibody Business of LifeSpan BioSciences (2018-2023)
Table 58. LifeSpan BioSciences Recent Developments
Table 59. Leading Biology Basic Information List
Table 60. Leading Biology Description and Business Overview
Table 61. Leading Biology NUP50 Antibody Products, Services and Solutions
Table 62. Revenue (US$ Million) in NUP50 Antibody Business of Leading Biology (2018-2023)
Table 63. Leading Biology Recent Developments
Table 64. RayBiotech Basic Information List
Table 65. RayBiotech Description and Business Overview
Table 66. RayBiotech NUP50 Antibody Products, Services and Solutions
Table 67. Revenue (US$ Million) in NUP50 Antibody Business of RayBiotech (2018-2023)
Table 68. RayBiotech Recent Developments
Table 69. OriGene Technologies Basic Information List
Table 70. OriGene Technologies Description and Business Overview
Table 71. OriGene Technologies NUP50 Antibody Products, Services and Solutions
Table 72. Revenue (US$ Million) in NUP50 Antibody Business of OriGene Technologies (2018-2023)
Table 73. OriGene Technologies Recent Developments
Table 74. Novus Biologicals Basic Information List
Table 75. Novus Biologicals Description and Business Overview
Table 76. Novus Biologicals NUP50 Antibody Products, Services and Solutions
Table 77. Revenue (US$ Million) in NUP50 Antibody Business of Novus Biologicals (2018-2023)
Table 78. Novus Biologicals Recent Developments
Table 79. Abcam Basic Information List
Table 80. Abcam Description and Business Overview
Table 81. Abcam NUP50 Antibody Products, Services and Solutions
Table 82. Revenue (US$ Million) in NUP50 Antibody Business of Abcam (2018-2023)
Table 83. Abcam Recent Developments
Table 84. Bethyl Laboratories Basic Information List
Table 85. Bethyl Laboratories Description and Business Overview
Table 86. Bethyl Laboratories NUP50 Antibody Products, Services and Solutions
Table 87. Revenue (US$ Million) in NUP50 Antibody Business of Bethyl Laboratories (2018-2023)
Table 88. Bethyl Laboratories Recent Developments
Table 89. ProSci Basic Information List
Table 90. ProSci Description and Business Overview
Table 91. ProSci NUP50 Antibody Products, Services and Solutions
Table 92. Revenue (US$ Million) in NUP50 Antibody Business of ProSci (2018-2023)
Table 93. ProSci Recent Developments
Table 94. Abnova Corporation Basic Information List
Table 95. Abnova Corporation Description and Business Overview
Table 96. Abnova Corporation NUP50 Antibody Products, Services and Solutions
Table 97. Revenue (US$ Million) in NUP50 Antibody Business of Abnova Corporation (2018-2023)
Table 98. Abnova Corporation Recent Developments
Table 99. Bioss Basic Information List
Table 100. Bioss Description and Business Overview
Table 101. Bioss NUP50 Antibody Products, Services and Solutions
Table 102. Revenue (US$ Million) in NUP50 Antibody Business of Bioss (2018-2023)
Table 103. Bioss Recent Developments
Table 104. GeneTex Basic Information List
Table 105. GeneTex Description and Business Overview
Table 106. GeneTex NUP50 Antibody Products, Services and Solutions
Table 107. Revenue (US$ Million) in NUP50 Antibody Business of GeneTex (2018-2023)
Table 108. GeneTex Recent Developments
Table 109. ABclonal Technology Basic Information List
Table 110. ABclonal Technology Description and Business Overview
Table 111. ABclonal Technology NUP50 Antibody Products, Services and Solutions
Table 112. Revenue (US$ Million) in NUP50 Antibody Business of ABclonal Technology (2018-2023)
Table 113. ABclonal Technology Recent Developments
Table 114. Proteintech Group Basic Information List
Table 115. Proteintech Group Description and Business Overview
Table 116. Proteintech Group NUP50 Antibody Products, Services and Solutions
Table 117. Revenue (US$ Million) in NUP50 Antibody Business of Proteintech Group (2018-2023)
Table 118. Proteintech Group Recent Developments
Table 119. Sino Biological Basic Information List
Table 120. Sino Biological Description and Business Overview
Table 121. Sino Biological NUP50 Antibody Products, Services and Solutions
Table 122. Revenue (US$ Million) in NUP50 Antibody Business of Sino Biological (2018-2023)
Table 123. Sino Biological Recent Developments
Table 124. United States Biological Basic Information List
Table 125. United States Biological Description and Business Overview
Table 126. United States Biological NUP50 Antibody Products, Services and Solutions
Table 127. Revenue (US$ Million) in NUP50 Antibody Business of United States Biological (2018-2023)
Table 128. United States Biological Recent Developments
Table 129. CUSABIO Technology Basic Information List
Table 130. CUSABIO Technology Description and Business Overview
Table 131. CUSABIO Technology NUP50 Antibody Products, Services and Solutions
Table 132. Revenue (US$ Million) in NUP50 Antibody Business of CUSABIO Technology (2018-2023)
Table 133. CUSABIO Technology Recent Developments
Table 134. St John's Laboratory Basic Information List
Table 135. St John's Laboratory Description and Business Overview
Table 136. St John's Laboratory NUP50 Antibody Products, Services and Solutions
Table 137. Revenue (US$ Million) in NUP50 Antibody Business of St John's Laboratory (2018-2023)
Table 138. St John's Laboratory Recent Developments
Table 139. Biobyt Basic Information List
Table 140. Biobyt Description and Business Overview
Table 141. Biobyt NUP50 Antibody Products, Services and Solutions
Table 142. Revenue (US$ Million) in NUP50 Antibody Business of Biobyt (2018-2023)
Table 143. Biobyt Recent Developments
Table 144. Jingjie PTM BioLab Basic Information List
Table 145. Jingjie PTM BioLab Description and Business Overview
Table 146. Jingjie PTM BioLab NUP50 Antibody Products, Services and Solutions
Table 147. Revenue (US$ Million) in NUP50 Antibody Business of Jingjie PTM BioLab (2018-2023)
Table 148. Jingjie PTM BioLab Recent Developments
Table 149. Wuhan Fine Basic Information List
Table 150. Wuhan Fine Description and Business Overview
Table 151. Wuhan Fine NUP50 Antibody Products, Services and Solutions
Table 152. Revenue (US$ Million) in NUP50 Antibody Business of Wuhan Fine (2018-2023)
Table 153. Wuhan Fine Recent Developments
Table 154. North America NUP50 Antibody Market Size by Country (2018-2023) & (US$ Million)
Table 155. North America NUP50 Antibody Market Size by Country (2024-2033) & (US$ Million)
Table 156. Europe NUP50 Antibody Market Size by Country (2018-2023) & (US$ Million)
Table 157. Europe NUP50 Antibody Market Size by Country (2024-2033) & (US$ Million)
Table 158. Asia-Pacific NUP50 Antibody Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 159. Asia-Pacific NUP50 Antibody Market Size by Region (2018-2023) & (US$ Million)
Table 160. Asia-Pacific NUP50 Antibody Market Size by Region (2024-2033) & (US$ Million)
Table 161. Asia-Pacific NUP50 Antibody Market Share by Region (2018-2023)
Table 162. Asia-Pacific NUP50 Antibody Market Share by Region (2024-2033)
Table 163. Latin America NUP50 Antibody Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 164. Latin America NUP50 Antibody Market Size by Country (2018-2023) & (US$ Million)
Table 165. Latin America NUP50 Antibody Market Size by Country (2024-2033) & (US$ Million)
Table 166. Middle East & Africa NUP50 Antibody Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 167. Middle East & Africa NUP50 Antibody Market Size by Country (2018-2023) & (US$ Million)
Table 168. Middle East & Africa NUP50 Antibody Market Size by Country (2024-2033) & (US$ Million)
Table 169. NUP50 Antibody Market Trends
Table 170. NUP50 Antibody Market Drivers
Table 171. NUP50 Antibody Market Challenges
Table 172. NUP50 Antibody Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Global NUP50 Antibody Market Size Year-over-Year 2018-2033 & (US$ Million)
Figure 2. Global NUP50 Antibody Market Size (US$ Million), 2018 VS 2022 VS 2033
Figure 3. Global NUP50 Antibody Market Share by Regions: 2022 VS 2033
Figure 4. Global NUP50 Antibody Forecasted Market Size Share by Region (2024-2033)
Figure 5. North America NUP50 Antibody Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 6. Europe NUP50 Antibody Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 7. Asia-Pacific NUP50 Antibody Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 8. Latin America NUP50 Antibody Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 9. Middle East & Africa NUP50 Antibody Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 10. Product Picture of Monoclonal
Figure 11. Global Monoclonal Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 12. Product Picture of Polyclonal
Figure 13. Global Polyclonal Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 14. Global NUP50 Antibody Market Size Share by Type: 2022 & 2033
Figure 15. North America NUP50 Antibody Revenue Market Share by Type (2018-2033)
Figure 16. Europe NUP50 Antibody Revenue Market Share by Type (2018-2033)
Figure 17. Asia-Pacific NUP50 Antibody Revenue Market Share by Type (2018-2033)
Figure 18. Latin America NUP50 Antibody Revenue Market Share by Type (2018-2033)
Figure 19. Middle East and Africa NUP50 Antibody Revenue Market Share by Type (2018-2033)
Figure 20. Immunochemistry (IHC) Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 21. Immunofluorescence (IF) Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 22. Immunoprecipitation (IP) Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 23. Western Blot (WB) Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 24. ELISA Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 25. Others Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 26. Global NUP50 Antibody Market Size Share by Application: 2022 & 2033
Figure 27. North America NUP50 Antibody Revenue Market Share by Application (2018-2033)
Figure 28. Europe NUP50 Antibody Revenue Market Share by Application (2018-2033)
Figure 29. Asia-Pacific NUP50 Antibody Revenue Market Share by Application (2018-2033)
Figure 30. Latin America NUP50 Antibody Revenue Market Share by Application (2018-2033)
Figure 31. Middle East and Africa NUP50 Antibody Revenue Market Share by Application (2018-2033)
Figure 32. NUP50 Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 33. Global Top 5 and Top 10 Players NUP50 Antibody Market Share in 2022
Figure 34. North America NUP50 Antibody Market Share by Country (2018-2033)
Figure 35. United States NUP50 Antibody Market Size (2018-2033) & (US$ Million)
Figure 36. Canada NUP50 Antibody Market Size (2018-2033) & (US$ Million)
Figure 37. Germany NUP50 Antibody Market Size (2018-2033) & (US$ Million)
Figure 38. France NUP50 Antibody Market Size (2018-2033) & (US$ Million)
Figure 39. U.K. NUP50 Antibody Market Size (2018-2033) & (US$ Million)
Figure 40. Italy NUP50 Antibody Market Size (2018-2033) & (US$ Million)
Figure 41. Russia NUP50 Antibody Market Size (2018-2033) & (US$ Million)
Figure 42. Nordic Countries NUP50 Antibody Market Size (2018-2033) & (US$ Million)
Figure 43. Asia-Pacific NUP50 Antibody Market Share by Region (2018-2033)
Figure 44. China NUP50 Antibody Market Size (2018-2033) & (US$ Million)
Figure 45. Japan NUP50 Antibody Market Size (2018-2033) & (US$ Million)
Figure 46. South Korea NUP50 Antibody Market Size (2018-2033) & (US$ Million)
Figure 47. Southeast Asia NUP50 Antibody Market Size (2018-2033) & (US$ Million)
Figure 48. India NUP50 Antibody Market Size (2018-2033) & (US$ Million)
Figure 49. Australia NUP50 Antibody Market Size (2018-2033) & (US$ Million)
Figure 50. Latin America NUP50 Antibody Market Share by Country (2018-2033)
Figure 51. Mexico NUP50 Antibody Market Size (2018-2033) & (US$ Million)
Figure 52. Brazil NUP50 Antibody Market Size (2018-2033) & (US$ Million)
Figure 53. Middle East & Africa NUP50 Antibody Market Share by Country (2018-2033)
Figure 54. Turkey NUP50 Antibody Market Size (2018-2033) & (US$ Million)
Figure 55. Saudi Arabia NUP50 Antibody Market Size (2018-2033) & (US$ Million)
Figure 56. UAE NUP50 Antibody Market Size (2018-2033) & (US$ Million)
Figure 57. Bottom-up and Top-down Approaches for This Report